With Turmoil In Its DNA, Yahoo Promotes Its ‘Big Data’ Play Genome
May 14, 2012 – 8:31 pm
The $270 million purchase of data management platform interclick last November was considered one of Yahoo’s sharpest moves during the period between the ouster of Carol Bartz as CEO and the replacement with Scott Thompson, whose reign was ended after less than six months this weekend.
Given the turmoil that has surrounded Yahoo’s executive ranks the last few years, it was no surprise that members of the advertising team opened Internet Week New York with a collective “business as usual” mien to herald the completion of the integration of Yahoo’s data stack into the interclick system, which collects data from third party sites, into a tool called Genome.
Aside from the CEO debacles, the introduction of Genome is reminder that although Yahoo fell from its perch as the leader in display ad sales to the space’s new hegemons, Google and Facebook, according to an eMarketer report in February, it isn't out of options. On the other hand, that doesn't mean it can just keep going as its been doing either. Yahoo is expected see its share of the U.S. display market fall to 9.1 percent in 2012, from 10.8 percent in 2011, eMarketer noted in that same report.
Yahoo’s dominant position is ever-more distant from 2008, when the portal’s share of U.S. display revenues peaked at 18.4 percent. But Yahoo, through all the company and shareholder mishegas of the past few years, has continued to generate revenue growth, and it is still way ahead of Microsoft, which will experience a decline of its share of display dollars to 4.4 percent this year from 4.5 percent in 2011, eMarketer estimates; bringing up the rear, AOL’s share will fall to 4 percent in 2012, from 4.3 percent last year.
With the landscape continuing to shift under all marketers, media brands and tech companies, the big question is not whether Genome will be able to at least help Yahoo maintain a healthy number three position, but whether the continuing shifts within the company will make it difficult to figure out how a product like Genome can fit into a larger strategy, which could evolve once yet another leadership regime is put in place.
Email This Post





"

Building digital consumer products for clients - in contrast to marketing campaigns - is a growing discipline for agencies, but they have to get the data right. That means embracing analytics and A/B testing from the outset; tapping customer databases; and using targeted ads to spread awareness among both existing customers and prospects.
